{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T20:08:56Z","timestamp":1778098136704,"version":"3.51.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The anti-Ma2 antibody is a well-known, specific marker of paraneoplastic limbic and brainstem encephalitis, mainly described in adult, especially in males with testicular germ cell tumor. Pediatric cases remain exceptionally rare. We present a child with anti-Ma2 antibody-associated cerebellar ataxia in whom nystagmus was identified as a core presenting symptom; the diagnosis was confirmed via cell-based assay (CBA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>An 11-year-old boy sought medical attention for symptoms such as vomiting, nystagmus, dizziness, slurred speech, and limb weakness. Routine laboratory tests and brain MRI were normal, simultaneously we ruled out infectious factors. Further limb coordination tests suggested the boy may have cerebellar ataxia. Based on clinical symptoms and the above tests, the boy underwent a comprehensive examination for suspected paraneoplastic neurological syndrome (PNS). Serum enzyme-linked immunospot test was positive (+) for anti-Ma2 antibodies and confirmed by CBA with a titer of 1:10. The boy was diagnosed with anti-Ma2 antibody-associated cerebellar ataxia. Subsequently, he received intravenous immunoglobulin (IVIG) and methylprednisolone (mPD) treatment and experienced significant symptomatic improvement. Complete resolution occurred by 38 days post-discharge, sustained through one-year follow-up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Nystagmus was first identified in pediatric patients with anti-Ma2 antibody-associated syndrome, expanding clinicians' knowledge of the phenotype in children. Our case demonstrates that IVIG and steroids induced rapid and sustained remission despite presumed cell-mediated immunity cases, with complete symptom resolution within 8 weeks and no recurrence at 1-year follow-up. We also emphasize CBA's superior accessibility and its higher sensitivity and specificity in detecting low-titer antibodies for detecting antibodies in autoimmune encephalitis, particularly in mild or atypical presentations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1659483","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:17Z","timestamp":1760502197000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Nystagmus as a core presenting sign in pediatric anti-Ma2 antibody-associated cerebellar ataxia: diagnostic implications from clinical and serological profiling"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiehui","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2013.00006","article-title":"Anabolic effects of IGF-1 signaling on the skeleton","volume":"4","author":"Tahimic","year":"2013","journal-title":"Front Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e557","DOI":"10.1212\/NXI.0000000000000557","article-title":"Atypical presentation of anti-Ma2-associated encephalitis with choreiform movement","volume":"6","author":"Lamby","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13256-022-03603-4","article-title":"Panhypopituitarism as the first sign of paraneoplastic limbic encephalitis in a patient with cured testicular cancer: a case report","volume":"16","author":"Lei","year":"2022","journal-title":"J Med Case Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1093\/cid\/ciz685","article-title":"Causes and clinical features of childhood encephalitis: a multicenter, prospective cohort study","volume":"70","author":"Britton","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer","volume":"340","author":"Voltz","year":"1999","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6666117","DOI":"10.1155\/2021\/6666117","article-title":"Autoimmune encephalitis in tunisia: report of a pediatric cohort","volume":"2021","author":"Douma","year":"2021","journal-title":"J Immunol Res."},{"key":"B9","first-page":"653","article-title":"Autoimmune neurological disorder with anti-Ma2\/Ta antibodies in a pediatric patient","volume":"20","author":"Boniel","year":"2018","journal-title":"Isr Med Assoc J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ejpn.2014.12.012","article-title":"An 8-year old boy with continuous spikes and waves during slow sleep presenting with positive onconeuronal antibodies","volume":"19","author":"Hu","year":"2015","journal-title":"Eur J Paediatr Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ejpn.2015.06.005","article-title":"Anti-Ma2-encephalitis in a 2 year-old child: a newly diagnosed case and literature review","volume":"19","author":"Mrabet","year":"2015","journal-title":"Eur J Paediatr Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00415-015-8012-0","article-title":"Paraneoplastic opsoclonus and cerebellar ataxia related to anti-Ma2 antibody: a case report","volume":"263","author":"M\u00e9l\u00e9","year":"2016","journal-title":"J Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12883-020-01929-4","article-title":"Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report","volume":"20","author":"Inui","year":"2020","journal-title":"BMC Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.26815\/acn.2022.00150","article-title":"A rare case of anti-Ma2 antibody-mediated autoimmune encephalomyelitis in childhood","volume":"30","author":"Kim","year":"2022","journal-title":"Annals Child Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"818382","DOI":"10.3389\/fimmu.2022.818382","article-title":"Enhanced immunomodulatory effect of intravenous immunoglobulin by fc galactosylation and nonfucosylation","volume":"13","author":"Mimura","year":"2022","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1136\/jnnp-2020-323055","article-title":"Central nervous system complications associated with immune checkpoint inhibitors","volume":"91","author":"Vogrig","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B17","doi-asserted-by":"publisher","first-page":"101858","DOI":"10.1016\/j.msard.2019.101858","article-title":"Detection of autoantibodies in central nervous system inflammatory disorders: clinical application of cell-based assays","volume":"38","author":"Molina","year":"2020","journal-title":"Mult Scler Relat Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e200038","DOI":"10.1212\/NXI.0000000000200038","article-title":"Comparison of fixed and live cell-based assay for the detection of aChR and muSK antibodies in myasthenia gravis","volume":"10","author":"Spagni","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.nrl.2020.06.015","article-title":"Progressive cerebellar ataxia with falsely positive anti-Ma2 antibodies","volume":"36","author":"Fern\u00e1ndez D\u00edaz","year":"2021","journal-title":"Neurologia (Engl Ed)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nrl.2016.05.010","article-title":"Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes","volume":"33","author":"Ortega","year":"2018","journal-title":"Neurologia (Engl Ed)."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1659483\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:23:24Z","timestamp":1760502204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1659483\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":20,"alternative-id":["10.3389\/fped.2025.1659483"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1659483","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1659483"}}